IL6 and central nervous system cancer: CNOT7 regulates the progression of glioma by affecting the E2F targets, G2/M checkpoint, TNF-α and IL6-JAK-STAT3 signaling pathway through NF-κB, leading to poor prognosis in glioma [10].